Immune checkpoint inhibitors such as programmed death 1/programmed cell death‐ligand 1 (PD‐1/PD‐L1) are now widely used as targets for immunotherapy, as they activate effector T cells to kill stomach cancer cells.4 The gene discussed is CD274; the disease is gastric cancer.